Tenofovir disoproxil succinate is a pharmaceutical raw material used in the manufacturing of antiviral medications. It serves as a key intermediate for the active pharmaceutical ingredient tenofovir disoproxil, which is employed in combination therapies for HIV and hepatitis B.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1637632-97-3
Tenofovir disoproxil
pharmaceutical raw material
Tenofovir disoproxil fumarate
pharmaceutical raw material
({[(Propan-2-yl)oxy]carbonyl}oxy)methyl hydrogen ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonate
pharmaceutical intermediate
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]-, bis(1-methylethyl) ester, 5-oxide
pharmaceutical intermediate
Auristatin F
pharmaceutical raw material
(R)-4-((6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile benzoate
pharmaceutical raw material
(S)-Alogliptin Benzoate Salt
pharmaceutical raw material
Propoxyphene hydrochloride
pharmaceutical raw material
[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate;butanedioic acid
CCGIINMVANPRGB-PFEQFJNWSA-N
C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.C(CC(=O)O)C(=O)O
—